Global Good Adds New Leaders to Global Health Technologies Team
November 7, 2019 Bellevue, WA
November 7, 2019 Bellevue, WA
GHT team to focus on inventing technology to improve the health of those who need it most.
Intellectual Ventures’ Global Good Fund has added new leadership to its Global Health Technologies team, a group of global health experts focused on inventing technology to solve some of humanity’s most daunting challenges. Dr. Peter Small will lead the team as its new director, joining international health leaders Drs. Julian Atim and Puneet Dewan to work alongside Noni Gachuhi.
“We’re excited to welcome Peter, Julian, and Puneet to the Global Good team. Along with Noni, the group brings deep expertise, diverse backgrounds, and effective leadership to advance our mission of bringing disruptive new technologies addressing key challenges in global health for the benefit of humanity,” said Maurizio Vecchione, executive vice president of Global Good. “We’re fortunate to have this world-class group of health innovators dedicate themselves to making a meaningful impact on the lives of people who need it most.”
The team’s primary focus will be to survey major global causes of morbidity and mortality to identify opportunities for technological solutions. The team will then collaborate with other experts and technologists at Global Good and IV Lab to develop technologies that meet the stringent requirements for some of the world’s most difficult markets.
“I’m a true believer in the power of technology and have seen firsthand how it can improve the health and wellbeing of millions of people,” said Dr. Small. “Global Good and the IV Lab offer the resources, partnerships and spirit of invention that empowers us to address the biggest problems in global health and bring our innovative solutions to market.”
Dr. Peter Small, Senior Director
Dr. Peter Small has a deep understanding of the potential for technology to drastically improve health care delivery in low- and middle-income countries, coming to Global Good from a Rockefeller Foundation Fellowship focused on the topic. Peter was a chief medical resident at the University of California, San Francisco at the dawn of the HIV epidemic, and subsequently moved to Stanford University where he completed an Infectious Disease fellowship and spent approximately a decade in Stanford’s Infectious Disease Division. During these years, he published pioneering molecular epidemiological papers that helped shape the public health response to the resurgence of tuberculosis (TB) and seminal papers on mycobacterial genomics.
In 2002, Peter was one of the first employees of the Bill & Melinda Gates Foundation where he developed the Foundation’s TB strategy, built its core partnerships and country programs, hired and managed the Foundation’s TB team, and oversaw a large portfolio of vaccine, drug, and diagnostic product development activities. In 2011, he relocated his family to New Delhi, where he established the Foundation’s TB program in India. In 2015, Peter joined Stony Brook University as the Founding Director of the University-wide Global Health Institute focused on the use of technology to deliver health care in remote Madagascar and Nepal.
Noni Gachuhi, MPH, Women & Child Health Lead
Noni Gachuhi, MPH, is a global public health professional with more than 18 years of on-the-ground experience living and working in Africa and Asia, designing and delivering health programs for reproductive health, malaria, and HIV prevention programs for bi-lateral and multilateral donors (USAID/PEPFAR, CDC, UNICEF, DFID) and private foundations. Noni has been with Global Good for more than three years and oversees a portfolio of products intended for primary health care in low-resource settings, particularly point-of-care diagnostics and AI-enabled technologies for clinical decision support for women and child health.
Dr. Julian Atim, Global Health Lead
Dr. Julian Atim is a physician from Uganda, experienced in product development, health marketing, strategic planning, and health policy development and implementation. Julian recently served as an Innovations Business Fellow at the Institute of Applied Life Sciences to advise PhD scientists and startups as they navigate translational research for health and life sciences. Previously, Julian served various managerial and technical roles in Uganda, including working as a clinician in rural and urban hospitals and providing technical assistance to government ministries of health in partnership with nonprofits and development partners such as PMI, USAID, UNICEF and UKAID. Julian received the 2015 African Excellence Award for her work that built a culture of malaria control through community health, health systems strengthening, and creative engagement of the private sector, which has been adopted into policy and rolled out to other countries in Africa. Julian holds a medical degree from Makerere University, a graduate degree in public health from Harvard University, and an MBA from Isenberg School of Management at the University of Massachusetts Amherst.
Dr. Puneet Dewan, Primary Health Care Lead
An internist trained at the University of California, Los Angeles and the University of Washington, Dr. Puneet Dewan started his career in global health delivery with the US Centers for Disease Control as an epidemic intelligence service officer, then with the San Francisco Tuberculosis (TB) Control Section. From 2006-2012, he supported the expansion of basic TB program services into a comprehensive patient-centered care system with the World Health Organization’s Southeast Asia regional office. From 2012-2018, Puneet led the Bill & Melinda Gates Foundation’s India TB delivery program, which helped India pioneer innovative private sector delivery models and guided development of technological tools to make these solutions scalable. During this time, he helped the Indian government create a financing strategy to scale these new tools and services nationwide. Puneet more recently served as a senior technical advisor to the World Bank, supporting results-based financing to encourage verified scale-up of these delivery models.
About Global Good
Millions of people suffer and die each year in poor countries from causes that humanity has the scientific and technical ability to solve. Funded by Bill Gates and focused on a shared vision with Nathan Myhrvold, Global Good invents technology to solve some of humanity's most daunting problems. We do this by collaborating with leading humanitarian organizations, forward-looking governments, research institutions, and corporate and private sector partners that bring our inventions to market. www.globalgood.com
Global Good recently conducted a World Cancer Day 2019 webinar called Artificial Intelligence for Identifying Cervical Precancer, which explores how a new Automated Visual Evaluation (AVE) technique will potentially increase access to quality cervical cancer screening worldwide.Read More
Building on a decade of success, IV is pleased to announce that Global Good projects have transitioned to the Bill & Melinda Gates Foundation and Gates Ventures.Read More
In a new study published in the journal Icarus, Nathan argues that astronomers don’t have as good a handle on the size and other physical characteristics of asteroids as they previously thought.Read More